In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: ArcBest Corp's current price exceeds the fair value estimate by over 30%, signaling potential overvaluation. Valuation variance is wide, with DCF and P/E indicating lower value, while EV/EBITDA and analyst targets suggest higher valuation. High downside risk and moderate financial strength reflect elevated investment risk despite strong growth prospects.